Opinion

... in response to Syphilis Treatment
  1. Gigazerker TV Gigazerker TV Nicaragua says:

    Hello there.

    I was diagnosed with optical neuropathy in my left eye two years ago (2019), this year the symptons show-up again but in my right eye, the sympton is the same, a particular loss of eyesight where there's a 'void-zone', when closing either eyes and trying to focus with the other eye open. Ofthalmology specialist describes some abnormalities in the back of both of my eyes, but think the problem goes beyond that structure

    So I get an MRI which is fine, neurology specialist thinks an LCR is needed. That was a very painful test but everything is good, then the TORCHS profile happened. I got positive for syphilis with a 1:16 reaction. Infectology specialist think I should treat me with a 4 million UI (six times a day) dose of sodic peneciline for two weeks. The days and the pain pass and the results come up positive again with a 1:32 reaction.

    Right now I'm doing another treatment, but with Ceftriaxona for two weeks. Today was day two of my treatment (06/12/2021). I'm writing this because I have nowhere else to go, I've witness the sorrow of my parents taking care of me since my first sympton appear, but now they think I might die of something worst and that saddnes me.

    I only wish I shouldn't have done so many mistakes in the past.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.